PortfoliosLab logo
GERN vs. MDT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GERN and MDT is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

GERN vs. MDT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Geron Corporation (GERN) and Medtronic plc (MDT). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

GERN:

-0.85

MDT:

0.09

Sortino Ratio

GERN:

-1.29

MDT:

0.02

Omega Ratio

GERN:

0.83

MDT:

1.00

Calmar Ratio

GERN:

-0.60

MDT:

-0.06

Martin Ratio

GERN:

-1.45

MDT:

-0.34

Ulcer Index

GERN:

40.99%

MDT:

6.36%

Daily Std Dev

GERN:

67.23%

MDT:

21.57%

Max Drawdown

GERN:

-98.65%

MDT:

-57.63%

Current Drawdown

GERN:

-97.74%

MDT:

-32.53%

Fundamentals

Market Cap

GERN:

$923.53M

MDT:

$103.43B

EPS

GERN:

-$0.21

MDT:

$3.61

PEG Ratio

GERN:

-2.38

MDT:

1.42

PS Ratio

GERN:

7.94

MDT:

3.08

PB Ratio

GERN:

3.44

MDT:

2.15

Total Revenue (TTM)

GERN:

$116.29M

MDT:

$24.61B

Gross Profit (TTM)

GERN:

$113.80M

MDT:

$15.68B

EBITDA (TTM)

GERN:

-$119.87M

MDT:

$6.89B

Returns By Period

In the year-to-date period, GERN achieves a -57.91% return, which is significantly lower than MDT's 2.43% return. Over the past 10 years, GERN has underperformed MDT with an annualized return of -9.08%, while MDT has yielded a comparatively higher 3.18% annualized return.


GERN

YTD

-57.91%

1M

4.93%

6M

-63.30%

1Y

-57.18%

3Y*

2.10%

5Y*

-1.54%

10Y*

-9.08%

MDT

YTD

2.43%

1M

-3.54%

6M

-3.67%

1Y

1.98%

3Y*

-3.28%

5Y*

-0.92%

10Y*

3.18%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Geron Corporation

Medtronic plc

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

GERN vs. MDT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GERN
The Risk-Adjusted Performance Rank of GERN is 99
Overall Rank
The Sharpe Ratio Rank of GERN is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of GERN is 88
Sortino Ratio Rank
The Omega Ratio Rank of GERN is 88
Omega Ratio Rank
The Calmar Ratio Rank of GERN is 1313
Calmar Ratio Rank
The Martin Ratio Rank of GERN is 88
Martin Ratio Rank

MDT
The Risk-Adjusted Performance Rank of MDT is 4444
Overall Rank
The Sharpe Ratio Rank of MDT is 5555
Sharpe Ratio Rank
The Sortino Ratio Rank of MDT is 3737
Sortino Ratio Rank
The Omega Ratio Rank of MDT is 3737
Omega Ratio Rank
The Calmar Ratio Rank of MDT is 4848
Calmar Ratio Rank
The Martin Ratio Rank of MDT is 4545
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GERN vs. MDT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Geron Corporation (GERN) and Medtronic plc (MDT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current GERN Sharpe Ratio is -0.85, which is lower than the MDT Sharpe Ratio of 0.09. The chart below compares the historical Sharpe Ratios of GERN and MDT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

GERN vs. MDT - Dividend Comparison

GERN has not paid dividends to shareholders, while MDT's dividend yield for the trailing twelve months is around 3.45%.


TTM20242023202220212020201920182017201620152014
GERN
Geron Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MDT
Medtronic plc
3.45%3.49%3.34%3.44%2.39%1.95%1.87%2.15%2.24%2.34%1.88%1.66%

Drawdowns

GERN vs. MDT - Drawdown Comparison

The maximum GERN drawdown since its inception was -98.65%, which is greater than MDT's maximum drawdown of -57.63%. Use the drawdown chart below to compare losses from any high point for GERN and MDT.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

GERN vs. MDT - Volatility Comparison

Geron Corporation (GERN) has a higher volatility of 22.51% compared to Medtronic plc (MDT) at 7.17%. This indicates that GERN's price experiences larger fluctuations and is considered to be riskier than MDT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

GERN vs. MDT - Financials Comparison

This section allows you to compare key financial metrics between Geron Corporation and Medtronic plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20212022202320242025
39.60M
8.29B
(GERN) Total Revenue
(MDT) Total Revenue
Values in USD except per share items

GERN vs. MDT - Profitability Comparison

The chart below illustrates the profitability comparison between Geron Corporation and Medtronic plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-50.0%0.0%50.0%100.0%20212022202320242025
97.0%
66.5%
(GERN) Gross Margin
(MDT) Gross Margin
GERN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Geron Corporation reported a gross profit of 38.40M and revenue of 39.60M. Therefore, the gross margin over that period was 97.0%.

MDT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Medtronic plc reported a gross profit of 5.51B and revenue of 8.29B. Therefore, the gross margin over that period was 66.5%.

GERN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Geron Corporation reported an operating income of -16.70M and revenue of 39.60M, resulting in an operating margin of -42.2%.

MDT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Medtronic plc reported an operating income of 1.65B and revenue of 8.29B, resulting in an operating margin of 19.9%.

GERN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Geron Corporation reported a net income of -19.84M and revenue of 39.60M, resulting in a net margin of -50.1%.

MDT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Medtronic plc reported a net income of 1.29B and revenue of 8.29B, resulting in a net margin of 15.6%.